Abstract
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
Ioannis Pakas, John P A Ioannidis, Katerina Malagari, Fotini N Skopouli, Haralampos M Moutsopoulos and Panayiotis G Vlachoyiannopoulos
The Journal of Rheumatology February 2002, 29 (2) 298-304;
Ioannis Pakas
John P A Ioannidis
Katerina Malagari
Fotini N Skopouli
Haralampos M Moutsopoulos
Panayiotis G Vlachoyiannopoulos
In this issue
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
Ioannis Pakas, John P A Ioannidis, Katerina Malagari, Fotini N Skopouli, Haralampos M Moutsopoulos, Panayiotis G Vlachoyiannopoulos
The Journal of Rheumatology Feb 2002, 29 (2) 298-304;